WO2005114212A3 - Diagnostics et therapies pour maladies associees au recepteur npy4 couple a la proteine g - Google Patents
Diagnostics et therapies pour maladies associees au recepteur npy4 couple a la proteine g Download PDFInfo
- Publication number
- WO2005114212A3 WO2005114212A3 PCT/EP2005/004905 EP2005004905W WO2005114212A3 WO 2005114212 A3 WO2005114212 A3 WO 2005114212A3 EP 2005004905 W EP2005004905 W EP 2005004905W WO 2005114212 A3 WO2005114212 A3 WO 2005114212A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disorders
- npy4
- diseases
- therapeutics
- diagnostics
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04012037 | 2004-05-21 | ||
EP04012037.0 | 2004-05-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005114212A2 WO2005114212A2 (fr) | 2005-12-01 |
WO2005114212A3 true WO2005114212A3 (fr) | 2006-02-02 |
Family
ID=34969114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/004905 WO2005114212A2 (fr) | 2004-05-21 | 2005-05-06 | Diagnostics et therapies pour maladies associees au recepteur npy4 couple a la proteine g |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005114212A2 (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1403380A1 (fr) * | 2002-09-27 | 2004-03-31 | Integragen | Gène humain de susceptibilité à l'obésité et leurs utilisations |
US6734166B1 (en) * | 2000-02-08 | 2004-05-11 | North Carolina State University | Method of reducing aluminum levels in the central nervous system |
-
2005
- 2005-05-06 WO PCT/EP2005/004905 patent/WO2005114212A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6734166B1 (en) * | 2000-02-08 | 2004-05-11 | North Carolina State University | Method of reducing aluminum levels in the central nervous system |
EP1403380A1 (fr) * | 2002-09-27 | 2004-03-31 | Integragen | Gène humain de susceptibilité à l'obésité et leurs utilisations |
Non-Patent Citations (2)
Title |
---|
BERGLUND MAGNUS M ET AL: "Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes.", EXPERIMENTAL BIOLOGY AND MEDICINE (MAYWOOD), vol. 228, no. 3, March 2003 (2003-03-01), pages 217 - 244, XP002344960, ISSN: 1535-3702 * |
PARKER R M C ET AL: "Regional distribution of Y-receptor subtype mRNAs in rat brain", EUROPEAN JOURNAL OF NEUROSCIENCE, vol. 11, no. 4, April 1999 (1999-04-01), pages 1431 - 1448, XP002344900, ISSN: 0953-816X * |
Also Published As
Publication number | Publication date |
---|---|
WO2005114212A2 (fr) | 2005-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005106492A3 (fr) | Diagnostic et traitement therapeutique des maladies associees au recepteur 3 de la chimiokine c-c (ccr3) | |
WO2004097421A3 (fr) | Diagnostics et traitements destines a des maladies associees au recepteur de type recepteur calcitonine (calcrl) | |
WO2005095973A3 (fr) | Methodes diagnostiques et therapeutiques pour des maladies associees au recepteur 54 couple a la proteine g (gpr54) | |
WO2005103702A3 (fr) | Methodes diagnostiques et therapeutiques pour lutter contre les maladies associees au recepteur 2 de la chimiokine cxc (cxcr2) | |
WO2005106471A3 (fr) | Diagnostics et therapies pour des maladies associees a un recepteur 4 de chimiokine c-c (ccr4) | |
WO2005095972A3 (fr) | Composes destines au diagnostic et au traitement de maladies associees au recepteur couple aux proteines g etb (etb) | |
WO2005040828A3 (fr) | Agents de diagnostic et de traitement des maladies associees au recepteur 49 couple aux proteines g (gpr49) | |
WO2004080373A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees au recepteur 2 active par la proteinase (par2) couple aux proteines g | |
WO2005050225A3 (fr) | Outils de diagnostic et de traitement de maladies associees au recepteur 84 couple aux proteines g (gpr84) | |
WO2005106489A3 (fr) | Diagnostics et therapies s'appliquant a des maladies associees aux recepteurs 5 des chimiokines c-c (ccr5) | |
WO2004082568A3 (fr) | Diagnostics et traitements contre des maladies associees au recepteur 5a du composant du complement (c5ar) | |
WO2005106488A3 (fr) | Diagnostics et therapeutique de maladies associees a l'adrenorecepteur beta-2 couple aux proteines g (adrb2) | |
WO2005108998A3 (fr) | Methodes de diagnostic et de traitement de maladies associees au recepteur couple aux proteines g adrenergique beta-3 (adrb3) | |
WO2005059546A3 (fr) | Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g 35 (gpr35) | |
WO2005040211A3 (fr) | Composes destines au diagnostic et au traitement de maladies associees au recepteur 1 couple aux proteines g (gpr1) | |
WO2005040825A3 (fr) | Diagnostics et therapeutiques pour maladies liees au recepteur 20 couple a la proteine g (gpr20) | |
WO2005114212A3 (fr) | Diagnostics et therapies pour maladies associees au recepteur npy4 couple a la proteine g | |
WO2005103711A3 (fr) | Agents diagnostiques et therapeutiques pour des maladies associees au recepteur 1 des chimiokines cxc (cxcr1) | |
WO2005095984A3 (fr) | Compositions diagnostiques et therapeutiques pour des maladies associees au recepteur adrenergique alpha 2a couple a la proteine g (adra2a) | |
WO2004082571A3 (fr) | Diagnostics et therapies pour maladies associees au recepteur 86 couple a la proteine g (gpr86) | |
WO2005040824A3 (fr) | Diagnostics et therapeutiques pour maladies liees au recepteur 24 couple a la proteine g (gpr24) | |
WO2004104577A3 (fr) | Approches diagnostiques et therapeutiques des maladies associees au recepteur 5-hydroxytryptamine 4 (5-ht4)(serotonine) | |
WO2005103690A3 (fr) | Diagnostic et therapeutique de maladies associees au recepteur de l'hormone de liberation de la corticotropine 2 (crhr2) | |
WO2004082572A3 (fr) | Diagnostics et therapies pour les maladies associees au recepteur 87 couple a la proteine g (gpr87) | |
WO2004099248A3 (fr) | Produits de diagnostic et de traitement de maladies associees au recepteur agtr2 couple aux proteines g (agtr2) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |